Fatal cytomegalovirus infection in two patients with systemic lupus erythematosus undergoing intensive immunosuppressive therapy: Role for cytomegalovirus vigilance and prophylaxis?

Journal of Clinical Rheumatology

Volumn 8, Issue 4, 2002, Pages 217-222

  Yoon, Kam Hon ^a   Fong, Kok Yong ^a   Tambyah, Paul Ananth ^a  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Cytomegalovirus; Cytomegalovirus prophylaxis; Cytomegalovirus vigilance; Immunosuppressive therapy; Systemic lupus erythematosus

Indexed keywords

ACICLOVIR; AMIKACIN; ANTINUCLEAR ANTIBODY; ANTIVIRUS AGENT; CEFTAZIDIME; CLARITHROMYCIN; CREATININE; CYCLOPHOSPHAMIDE; DNA ANTIBODY; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; RIBONUCLEOPROTEIN ANTIBODY; VANCOMYCIN; VINCRISTINE;

ACALCULOUS CHOLECYSTITIS; ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BRAIN ATROPHY; CASE REPORT; CONFUSION; CYTOMEGALOVIRUS INFECTION; FATALITY; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LUNG HEMORRHAGE; LUNG INFILTRATE; LUPUS ERYTHEMATOSUS NEPHRITIS; OPPORTUNISTIC INFECTION; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINITIS; SEIZURE; SHOCK; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VIRUS ENCEPHALITIS; VIRUS PNEUMONIA; VIRUS REACTIVATION;

EID: 0036348412     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200208000-00011     Document Type: Article

References (38)

1. A multicenter study of outcome in systemic lupus erythematosus: II. Causes of death
2. Morbidity and mortality in systemic lupus erythematosus during a 5-year period: A multicenter prospective study of 1,000 patients
3. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus
4. Fatal infections in systemic lupus erythematosus
5. Systemic lupus erythematosus and infection: A controlled and prospective study including an epidemiological group
6. Fatal interstitial pneumonia due to cytomegalovirus following cyclophosphamide treatment in a patient with systemic lupus erythematosus
7. Complement-fixing antibodies against cytomegalovirus in different parts of the world
8. Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1
9. Cytomegalovirus: Disease syndromes and treatment
10. Thrombocytopenia in systemic lupus erythematosus associated with cytomegalovirus infection
11. Cytomegalovirus-associated hemophagocytic syndrome
12. Cytomegaloviral acalculous cholecystitis in acquired immunodeficiency syndrome patients
13. Systemic lupus erythematosus and concurrent cytomegalovirus vasculitis: Diagnosis by antemortem skin biopsy
14. Molecular methods in the diagnosis of infections in the immunocompromised host
15. Use of molecular assays in the diagnosis and monitoring of cytomegalovirus disease following renal transplantation
16. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence based amplification
17. Foscarnet penetrates the blood brain barrier: Rationale for therapy of cytomegalovirus encephalitis
18. CMV encephalitis during ganciclovir therapy of CMV retinitis
19. Human cytomegalovirus infection and systemic lupus erythematosus
20. A longitudinal study of human cytomegalovirus serology and viruria fails to detect active viral infection in 20 systemic lupus erythematosus patients
21. Cytomegalovirus-induced flare of systemic lupus erythematosus
22. Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection
23. Spontaneous recovery from cytomegalovirus pneumonia
24. Cytomegalovirus interstitial pneumonitis in a patient with systemic lupus erythematosus
25. Case of SLE with fatal acute adrenal insufficiency caused by contagious cytomegalovirus infection
26. Diagnosis and treatment of a case of cutaneous cytomegalovirus infection with a dramatic clinical presentation
27. Cytomegalic inclusion disease in patients with systemic lupus
28. Disseminated cytomegalovirus disease in a patient with systemic lupus erythematosus not undergoing immunosuppressive therapy
29. Risks factors for infection in Malaysian patients with systemic lupus erythematosus
30. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: A phase I study
31. PCR of plasma for cytomegalovirus DNA identifies HIV-infected persons most likely to benefit from oral ganciclovir prophylaxis
32. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation
33. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic marrow transplant
34. Cytomegalovirus disease in adult marrow transplant recipients receiving ganciclovir prophylaxis: A retrospective study
35. Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection
36. Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: Examination of a preemptive plan of ganciclovir therapy
37. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients
38. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation